Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. - Wikidata - wikimedia - TriplyDB

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

http://www.wikidata.org/entity/Q39636313

about

Precision medicine: from pharmacogenomics to pharmacoproteomics Precision targeted therapy of ovarian cancer A Golden Age for Working with Public Proteomics Data PDGFR-beta pathway Collaboration to Accelerate Proteogenomics Cancer Care: The Department of Veterans Affairs, Department of Defense, and the National Cancer Institute's Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Network.Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.OpenSlice: Quantitative data sharing from HyperPeaks to global ion chromatograms (GICs).An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.Characterization of developmental defects in the forebrain resulting from hyperactivated mTOR signaling by integrative analysis of transcriptomic and proteomic data Extensive Peptide Fractionation and y1 Ion-Based Interference Detection Method for Enabling Accurate Quantification by Isobaric Labeling and Mass Spectrometry.MYC Deregulation in Primary Human Cancers.Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets Detecting protein variants by mass spectrometry: a comprehensive study in cancer cell-lines.Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data Sets.Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer.Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer.Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.Understanding cell signaling in cancer stem cells for targeted therapy - can phosphoproteomics help to reveal the secrets?Proteogenomic integration reveals therapeutic targets in breast cancer xenografts Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer.Spatiotemporal proteomic profiling of human cerebral development.Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells.Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer Adaptive Multiview Nonnegative Matrix Factorization Algorithm for Integration of Multimodal Biomedical Data.Pathways to Genome-targeted Therapies in Serous Ovarian Cancer.Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.Approaches to identify kinase dependencies in cancer signalling networks.Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer Quantitative proteomics: challenges and opportunities in basic and applied research.Identification of Pharmacologically Tractable Protein Complexes in Cancer Using the R-Based Network Clustering and Visualization Program MCODER.Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells.Methods, Tools and Current Perspectives in Proteogenomics.Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.A pan-cancer analysis of secreted Frizzled-related proteins: re-examining their proposed tumour suppressive function.Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease.Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer.Insights into molecular therapy of glioma: current challenges and next generation blueprint Functional variomics and network perturbation: connecting genotype to phenotype in cancer.

P2860

Q28076871-0E2F92FB-6302-48E4-A8B7-95F1C989CE6A Q28078658-C567A156-BAB2-4A49-AA64-E98B2CE7893F Q28519626-09172772-4CE8-4A5B-878B-A1A620585754 Q30230885-938A03BC-5E39-4837-A2B5-96448E840B74 Q30238490-87857406-CA04-423D-9E13-A2739AAA2755 Q30834140-7C3218CF-797F-4225-B3FE-43D08301F5AA Q31115964-4ED573FE-3BB9-4E56-8889-3D65D2B21D98 Q33655094-3915C991-D9AD-48DA-AC4B-08C03D58F340 Q33767612-287693BC-B4B9-4BC6-92A4-BD147A5D40C3 Q33787283-D53C9320-8F14-4179-BE94-32F0AE844282 Q33836755-036BB6AF-009F-418A-95C8-EED1C582D0CB Q33882864-B26D0B85-F5FE-4137-880E-2691DB1C28EC Q33903831-F00E7A75-1216-4514-9F1F-39BBB95E9289 Q33913055-D6EDE437-91E7-4883-BE1A-FB032094E447 Q36347054-B1D44D34-B77A-40DA-BA0D-EB8FF6190722 Q37575966-D555CBF2-80A2-4CA8-906B-1ED46D060540 Q37625637-2599A5F5-001F-407D-B93D-DCF46BB211A9 Q37651932-B1ABFC9C-C67F-47BC-B78F-74CD612AC874 Q37705031-9E32B16B-7E5E-488B-BB46-CA5F389AE8BF Q37728625-9E6AD89B-AFBD-4ADB-9EC1-7F3CCF1FAA96 Q37736390-B27421D2-CF09-44A9-8B73-0407D8FB683E Q37739177-4CBAD495-55B5-48EB-A05B-A7A303430509 Q38373307-41931E87-1A9A-4EAC-A5C5-AC9FD3448278 Q38602104-3A97CECC-C53A-4D57-8ADC-04FB8FDEC036 Q38602962-105217E1-5CA3-4965-841B-50A4D6F62A41 Q38611086-042E3A54-6DE2-443E-A205-D247413D0E5E Q38621094-C3162A37-4C20-4DEE-8690-91DC4E4FE34F Q38660073-A86E9964-E1B9-4E57-8CFA-39FD9FEC34F6 Q38660465-6BC9DDD0-05DF-4B3D-A122-8732326C0239 Q38672374-8B326BA0-A440-4899-8D04-34EDB60FD567 Q38676266-26F912AB-1780-424A-B095-071FC50A6CBB Q38687169-455881AC-C094-4558-8363-FDF2349FAB44 Q38695855-CACA71FD-415C-4ACB-8420-3C10BE1B6E6C Q38812665-BD75F46F-1F03-417C-AE65-86C224B9E92C Q38824059-20D67D2E-F35E-45F2-89B0-3274C7CD755B Q38952038-C7B097E6-1135-490C-8D2B-492DF1BB4FBD Q38989305-AB4F3DB7-18FF-4670-BE17-5AE43E2A9CB9 Q39175714-61EB7FC4-23E8-45C8-B82A-F1523831C311 Q39187306-250506FE-86A7-4FB9-88DE-98090CD91F88 Q39201399-E8E79EF5-11CC-41F5-8257-2A7D2B004B8F

P2860

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

http://www.wikidata.org/entity/Q39636313

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

@en

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

@nl

type

label

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

@en

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

@nl

prefLabel

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

@en

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

@nl

P1433

Q39636313-FC6E7B8F-A55F-42B6-AC03-3DD3A3B366C8

P1476

Q39636313-FD34FE5A-0304-4A37-8D07-E922E571E75E

P2093

Q39636313-052A8CB2-2EC5-44DB-94CE-94E366648826

Q39636313-07F60704-2087-40FB-B670-69C24AA76E3B

Q39636313-141F71E6-7659-4C9D-92FD-D4E99013C831

Q39636313-1CFD19C4-D8E8-402D-8514-9A4E389842DE

Q39636313-1E6D2613-8F10-4E78-B2ED-57E367CAF5A9

Q39636313-27EAA0FD-4964-4AF6-8F06-467C82744F72

Q39636313-2BF9019A-C2E8-4607-989A-C49FB188CDEA

Q39636313-2C8E3CBD-4DEB-4E3C-B714-9AE1C1F35D6A

Q39636313-35270A9C-C657-4167-A72E-C8EB79CE2B2D

Q39636313-38A688AF-B479-47D9-A342-69132AA67B21

P2860

Q39636313-03A08059-59A2-4B2A-AB53-886401AC02E9

Q39636313-044BCA0B-C245-4286-844E-2AE738D278BE

Q39636313-0B63A22C-D4D6-4FFA-821D-69B6F599F4D0

Q39636313-2032D1CD-C451-4C9E-8523-10F2AC123C73

Q39636313-228E183B-9DF2-4E90-9EB0-B44914D6E1C8

Q39636313-26C12F42-3823-4904-B324-E87B546D0C6C

Q39636313-28CAB298-417B-4530-A5A5-3D69DB4C9AB8

Q39636313-2B347390-1015-4955-98D0-606AC7F7B586

Q39636313-3A3A587C-9355-4EBE-990C-4301776F1B91

Q39636313-3B08F1A7-3F41-4EE5-9F9F-367C9C98CBB8

P304

Q39636313-1D1D8222-9625-4423-A6AA-1FA46294D912

P31

Q39636313-1CE8F992-C4DE-46D8-99E0-4D3502CFBF69

P356

Q39636313-F02483F1-4BBD-42AF-AC23-BCBB197A52AB

P407

Q39636313-FBDB8F03-219E-405F-AACF-8C1A561F5DEB

P433

Q39636313-6A5DDE08-382F-4277-94E0-2E595347250D

P478

Q39636313-9ECE0330-EEF2-4E3A-ABB1-182DB1FD9F19

P50

Q39636313-090DF809-CBA6-46BF-A622-3984A3C1CC6C

Q39636313-224EB784-E7CB-41AD-93EC-E7EFE529648A

Q39636313-2D0472A1-921A-432F-8DDB-547E02845034

Q39636313-2DCA142C-DBB1-4E8E-BFD5-9E0AA108B64A

Q39636313-6A392D72-DB20-4DA6-8C5B-73A52EBCDE0C

Q39636313-91B26008-DF1D-4F7D-B174-042B57A72C0B

Q39636313-C633612E-9A7C-4DB3-9046-460ACA80D27E

Q39636313-F82FDC99-C597-45FC-893D-20DEE3D72EDB

P577

Q39636313-1460B72D-2C4B-4EC7-8F64-5079A28810C1

P698

Q39636313-AAA514B7-68AF-46B1-8AC6-0D1A92C5DE0B

P921

Q39636313-FF403539-FFCC-45F6-BD9A-01AA02150651

P932

Q39636313-9A495B2A-855D-4C8F-A204-8040E08519AA

P356

J.CELL.2016.05.069

P1433

P1476

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

@en

P2093

Akhilesh Pandey

http://www.w3.org/2001/XMLSchema#string

Bai Zhang

http://www.w3.org/2001/XMLSchema#string

Bing Zhang

http://www.w3.org/2001/XMLSchema#string

CPTAC Investigators

http://www.w3.org/2001/XMLSchema#string

Caitlin Choi

http://www.w3.org/2001/XMLSchema#string

Chaochao Wu

http://www.w3.org/2001/XMLSchema#string

Daniel W Chan

http://www.w3.org/2001/XMLSchema#string

Douglas A Levine

http://www.w3.org/2001/XMLSchema#string

Emily S Boja

http://www.w3.org/2001/XMLSchema#string

Feng Yang

http://www.w3.org/2001/XMLSchema#string

P2860

WGCNA: an R package for weighted correlation network analysis

Hallmarks of Cancer: The Next Generation

HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins

PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b

Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination

Integrated genomic analyses of ovarian carcinoma

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Proteogenomic characterization of human colon and rectal cancer

Comprehensive genomic characterization of squamous cell lung cancers.

Variation and genetic control of protein abundance in humans

P304

755-765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2016.05.069

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27372738

http://www.w3.org/2001/XMLSchema#string

P921

P932

4967013

http://www.w3.org/2001/XMLSchema#string